Long-term safety and efficacy of imatinib mesylate (Gleevecâ) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study

Nom du journal : Am J Hematol

Année : 2013

Volume : 88

Page de départ : 1

Page de fin : 4

Auteurs: Rousselot P, Cony-Makhoul P, Nicolini F, Mahon FX, Berthou C, Réa D, Reiffers J, Bornand A, Saint-Jean O, Guilhot J, Guilhot F, on behalf of the French Intergroup For Chronic Myelogenous Leukemia (Fi-LMC), on behalf of the French Intergroup For Chronic Myelogenous Leukemia (Fi-LMC),